blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1050302

EP1050302 - Method for treating abnormal cell proliferation in the brain [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  11.01.2002
Database last updated on 25.09.2024
Most recent event   Tooltip11.01.2002Application deemed to be withdrawnpublished on 27.02.2002  [2002/09]
Applicant(s)For all designated states
Aventis Pharma S.A.
20, avenue Raymond Aron
92160 Antony / FR
[2000/45]
Inventor(s)01 / Bissery, Marie-Christine
5 rue Henri Poincaré
94400 Vitry Sur Seine / FR
02 / Renard, Alain
2 rue Guynemer
75006 Paris / FR
03 / Besenval-Milleron, Michèle
6/8 rue Vulpian
75013 Paris / FR
[2000/45]
Application number, filing date99108516.803.05.1999
[2000/45]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1050302
Date:08.11.2000
Language:EN
[2000/45]
Search report(s)(Supplementary) European search report - dispatched on:EP31.01.2000
ClassificationIPC:A61K31/337
[2000/45]
CPC:
A61K31/337 (EP,US)
Designated contracting statesFR [2001/30]
Former [2000/45]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
TitleGerman:Verfahren zur Behandlung von abnormaler Zellproliferation im Gehirn[2000/45]
English:Method for treating abnormal cell proliferation in the brain[2000/45]
French:Procédé de traitement de la prolifération anormale cellulaire dans le cerveau[2000/45]
Examination procedure11.08.2001Application deemed to be withdrawn, date of legal effect  [2002/09]
13.09.2001Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2002/09]
Fees paidPenalty fee
Penalty fee Rule 85b EPC 1973
26.06.2001M01   Not yet paid
Additional fee for renewal fee
31.05.200103   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9413654  (RHONE POULENC RORER SA [FR]) [X] 1-27 * abstract * * example - * * page 26, line 13 - page 29, line 18; claim - *;
 [X]WO9632387  (RHONE POULENC RORER SA [FR], et al) [X] 1-27 * abstract * * example - * * page 33, line 22 - page 37, line 9; claim - *;
 [A]WO9631493  (RHONE POULENC RORER SA [FR], et al) [A] 1-27 * abstract * * example - * * page 37, line 28 - page 41, line 18; claim - *;
 [A]  - SHU-HUI CHEN ET AL., "TAXOL STRUCTURE-ACTIVITY RELATIONSHIPS: SYNTHESIS AND BIOLOGICAL EVALUATION OF TAXOL ANALOGS MODIFIED AT C-7", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (1994), vol. 4, no. 18, pages 2223 - 2228, XP000869521 [A] 1-27 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0960-894X(00)80075-X
 [A]  - SHU-HUI CHEN ET AL., "SERENDIPITOUS SYNTHESIS OF A CYCLOPROPANE-CONTAINING TAXOL ANALOG VIA ANCHIMERIC PARTICIPATION OF AN UNACTIVATED ANGULAR METHYL GROUP", J. ORG. CHEM., (1993), vol. 58, no. 17, pages 4520 - 4521, XP000867047 [A] 1-27 * the whole document *

DOI:   http://dx.doi.org/10.1021/jo00069a005
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.